Insulin, Sale of Medicines for Diabetes Triples in India

by Julia Samuel on  November 14, 2017 at 4:08 PM Diabetes News
RSS Email Print This Page Comment bookmark
Font : A-A+

Along with the steadily increasing number of diabetics, sale of anti-diabetic medicines, including insulin, has zoomed in India, says a study.
Insulin, Sale of Medicines for Diabetes Triples in India
Insulin, Sale of Medicines for Diabetes Triples in India

The findings led by Anoop Misra, Chairman at Fortis C-DOC Hospital, showed that from Rs 151.2 crore in 2008, the sale of insulin (especially newer insulin) rose to Rs 842 crore in 2016.

Sales of oral drug (especially newer ones) also went up from Rs 278.5 crores in 2013 to Rs 700 crore in 2016.

The spike could be attributed to the rising number of patients, increased availability and aggressive marketing by pharmaceutical companies.

On the other hand, the affordability and accessibility of the anti-diabetic therapy to lower socio-economic strata remained inadequate, the study said.

"Increasing sales of high cost medications as shown by our data are particularly worrisome since most Indians pay out of their pocket and nearly seven percent experience catastrophic expenditure for diabetes," Misra said.

According to the World Health Organization (WHO), the number of adults suffering from diabetes has risen from 4.7 percent of the global population in 1980 to 8.5 percent in 2014.

In 2015, the disease touted as lifestyle epidemic affected 415 million people worldwide while there were 69.1 million people with diabetes in India -- the second highest in the world after China, which had 109 million people, according to the report "Diabetes Atlas" released by the International Diabetes Federation (IDF).

"India has to take several stringent measures to ensure that there is a balancing mechanism in place, education of physicians, tighter regulations on price control and stricter norms for pharmaceutical companies around new drugs and marketing ethics," Misra added.

The research was based on the data of sales trends from all top selling drugs (20 brands) for the past nine years (between December 2008 and December 2016), with emphasis on anti-diabetic drugs.

Source: IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Diabetic Retinopathy Drug Toxicity Diabetes Diabetic Diet Diabetes - Essentials Diabetes - Self-Monitoring of Blood Glucose (SMBG) Insulin Delivery Devices Diabetes and Exercise Stress Relief Through Alternative Medicine Stress and the Gender Divide 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...